Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kelly G. Sprankle is active.

Publication


Featured researches published by Kelly G. Sprankle.


Journal of Medicinal Chemistry | 2009

Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor

Qi Chao; Kelly G. Sprankle; Robert M. Grotzfeld; Andiliy G. Lai; Todd A. Carter; Anne Marie Velasco; Ruwanthi N. Gunawardane; Merryl Cramer; Michael F. Gardner; Joyce K. James; Patrick Parvis Zarrinkar; Hitesh Patel; Shripad S. Bhagwat

Treatment of AML patients with small molecule inhibitors of FLT3 kinase has been explored as a viable therapy. However, these agents are found to be less than optimal for the treatment of AML because of lack of sufficient potency or suboptimal oral pharmacokinetics (PK) or lack of adequate tolerability at efficacious doses. We have developed a series of extremely potent and highly selective FLT3 inhibitors with good oral PK properties. The first series of compounds represented by 1 (AB530) was found to be a potent and selective FLT3 kinase inhibitor with good PK properties. The aqueous solubility and oral PK properties at higher doses in rodents were found to be less than optimal for clinical development. A novel series of compounds were designed lacking the carboxamide group of 1 with an added water solubilizing group. Compound 7 (AC220) was identified from this series to be the most potent and selective FLT3 inhibitor with good pharmaceutical properties, excellent PK profile, and superior efficacy and tolerability in tumor xenograft models. Compound 7 has demonstrated a desirable safety and PK profile in humans and is currently in phase II clinical trials.


Biotechnology and Bioengineering | 1999

Solid-phase synthesis of a library of functionalized aminodiol scaffolds

Peter W. Davis; Stephen A. Osgood; Normand Hebert; Kelly G. Sprankle; Eric E. Swayze

A combinatorial library motif has been developed based on orthogonally protected aminodiol scaffolds. Amine functionality was derivatized by commercially available electrophiles including carboxylic acids, sulfonyl chlorides, isocyanates, and aldehydes. A hydroxyl moiety was converted to a carbamate linkage, allowing a variety of amines to be incorporated. The scaffold was anchored to TentaGel at the second hydroxyl via a succinyl linker, which was hydrolyzed by mild aqueous basic conditions. The method was used to make a library of about 17,000 different members in mixtures of 5 per sample.


Nucleosides, Nucleotides & Nucleic Acids | 1997

An Efficient and Scalable Synthesis of Arabinosylguanine and 2′-Deoxy-2′-Fluoro-guanosine

Bruce S. Ross; Robert H. Springer; Kelly G. Sprankle; Guillermo Vasquez

Abstract An efficient conversion from commercially available 2, 6-diaminopurine-2′, 3′, 5′-tri-O-benzyl arabinoside to arabinosylguanine and its further transformation to 2′-deoxy-2′-fluoro-guanosine is outlined. This process has been used to produce more than one hundred grams of final product.


Archive | 1994

Peptide nucleic acid combinatorial libraries and improved methods of synthesis

Phillip Dan Cook; John Kiely; Kelly G. Sprankle


Journal of the American Chemical Society | 1995

SINGLE AND BIS PEPTIDE NUCLEIC ACIDS AS TRIPLEXING AGENTS : BINDING AND STOICHIOMETRY

Michael C. Griffith; Lisa M. Risen; Michael J. Greig; Elena A. Lesnik; Kelly G. Sprankle; Rich H. Griffey; John Kiely; Susan M. Freier


Journal of Medicinal Chemistry | 2003

Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors.

Xiaoming Li; Sam Chu; Victoria A. Feher; Mitra Khalili; Zhe Nie; Stephen Margosiak; Victor I. Nikulin; James Levin; Kelly G. Sprankle; Martina E. Tedder; Robert J. Almassy; Krzysztof Appelt; Kraig M. Yager


Archive | 1995

Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions

Phillip Dan Cook; Yogesh S. Sanghvi; Kelly G. Sprankle; Bruce S. Ross; Rich H. Griffey


Archive | 1996

Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom

Phillip Dan Cook; Yogesh S. Sanghvi; Kelly G. Sprankle; Bruce S. Ross; Rich H. Griffey; Robert H. Springer


Archive | 1995

Peptide nucleic acid conjugates

Peter E. Nielsen; Ole Buchardt; Soren Holst Sonnechsen; Jesper Lohse; Michael Egholm; Muthiah Manoharan; John Kiely; Michael C. Griffith; Kelly G. Sprankle


Archive | 1995

Pna combinatorial libraries and improved methods of synthesis

Phillip Dan Cook; John Kiely; Kelly G. Sprankle

Collaboration


Dive into the Kelly G. Sprankle's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge